Skyline Therapeutics is a fully integrated gene and cell therapy company dedicated to the discovery, development and delivery of innovative therapies. Through the development of transformative therapies, we are committed to making a meaningful impact on the lives of patients with devastating diseases.
Led by a world-class team of experts and leaders in science, technology and business who brings to Skyline industry-leading know-how, we have established a proprietary AAV gene therapy platform that integrates novel capsid engineering and vector design, analytical and process development, and state-of-the-art GMP manufacturing capabilities that support large scale clinical-grade vector production. Based on our robust end-to-end AAV-based platform, we are rapidly advancing a pipeline of diversified programs to address multiple serious diseases that could be altered through a disruptive gene and cell therapy approach.
Founded in 2019, Skyline Therapeutics is headquartered in China, with well-established research, development and manufacturing capabilities in Shanghai and Hangzhou.
Company Details
- Employees
- 26
- Founded
- -
- Address
- 2727 Jinke Road, Zhangjiang Hi-Tech Park,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- Shanghai
Skyline Therapeutics Questions
Skyline Therapeutics's LinkedIn profile is https://cn.linkedin.com/company/skytx
Skyline Therapeutics has
26 employees.
View email and phone details for 26
employees at Skyline Therapeutics.
Skyline Therapeutics's industry is
Pharmaceutical Manufacturing
Skyline Therapeutics's top competitors are
Sironax,
Affamed Therapeutics,
Neurophth Therapeutics / 纽福斯生物科技有限公司,
Frontera Therapeutics,
Ocudyne Inc,
Olix Pharmaceuticals, Inc.,
Everest Medicines,
Ansun Biopharma, Inc.,
D3 Bio,
Amarna Therapeutics.
Skyline Therapeutics's categories are Pharmaceutical Manufacturing
Skyline Therapeutics's founding year is 2019
